Ramani R Ranatunge

This inventor holds 14 USPTO granted patents. Top assignees: Nitromed, Inc., Nicox S.a.. Active years: 2007-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ramani R Ranatunge. Retrieved from https://idiyas.com/inventor/ramani-r-ranatunge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14

% Patents Active = 21.4

Average Co-Inventor Count = 6.8

ph-index = 6

Forward Citations = 139(Granted Patents)

Company Filing History:

Years Active: 2007-2012

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8304409 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2012-11-06),

2. 8222277 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2012-07-17),

3. 8088762 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2012-01-03),

4. 7883714 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2011-02-08),

5. 7838023 - Furoxan compounds, compositions and methods of use (2010-11-23),

6. 7754772 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2010-07-13),

7. 7595313 - Nitric oxide donating diuretic compounds, compositions and methods of use (2009-09-29),

8. 7442802 - Cyclooxygenase-2 selective inhibitors, compositions and methods of use (2008-10-28),

9. 7396829 - Nitric oxide enhancing diuretic compounds, compositions and methods of use (2008-07-08),

10. 7282519 - Nitrosated and nitrosylated diuretic compounds, compositions and methods of use (2007-10-16),

11. 7244753 - Cyclooxygenase-2 selective inhibitors, compositions and methods of use (2007-07-17),

12. 7238814 - Compositions of S-nitrosothiols and methods of use (2007-07-03),

13. 7211598 - Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use (2007-05-01),

14. 7163958 - Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use (2007-01-16),

Title: Ramani R. Ranatunge: Innovator in Nonsteroidal Anti-inflammatory Compounds

Introduction

Ramani R. Ranatunge is a prominent inventor based in Lexington, MA, known for her significant contributions to the field of pharmaceuticals, particularly in the development of nonsteroidal anti-inflammatory drugs (NSAIDs). With a remarkable portfolio of 14 patents, her work focuses on enhancing the safety and efficacy of NSAIDs through innovative formulations that incorporate nitrosation techniques.

Latest Patents

Among her latest patents is an invention titled "Nitrosated Nonsteroidal Anti-inflammatory Compounds, Compositions and Methods of Use." This groundbreaking work outlines novel nitrosated NSAIDs and their pharmaceutically acceptable salts, resulting in compositions that not only target inflammation, pain, and fever but also aim to treat gastrointestinal disorders and facilitate wound healing. The invention emphasizes methods for countering toxicities resulting from traditional NSAID use, providing substantial advancements in treating various inflammatory diseases, including renal and ophthalmic conditions. These compositions may include compounds that donate or release nitric oxide, reinforcing the therapeutic potential of the NSAIDs.

Career Highlights

Ramani’s career has seen her contribute to esteemed companies such as Nitromed, Inc. and Nicox S.A., where she applied her expertise in pharmacology and drug formulation. Her innovative spirit has been instrumental in advancing the pharmaceutical landscape, particularly in the area of nonsteroidal anti-inflammatory therapies.

Collaborations

Throughout her career, Ramani has collaborated with notable professionals in the field, including David S. Garvey and Subhash P. Khanapure. These partnerships have likely enriched her research perspectives and contributed to her success as an inventor.

Conclusion

Ramani R. Ranatunge’s inventive spirit and dedication to pharmaceutical innovation continue to advance the medical community's understanding and utilization of nonsteroidal anti-inflammatory drugs. Her work not only enhances therapeutic options but also ensures safer administration for patients, reinforcing the importance of innovations in drug development.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]